Patrik Frei
Education
EPFL
PhD, 2002-01-01 - 2006-01-01
University of St.Gallen
lic.oec.HSG, Finance 1994-01-01 - 1999-01-01
KKS
, -Work Experience
Venture Valuation AG
Current
Venture Valuation AG
CELforPharma
Current
CELforPharma
Kleinkraftwerk Birseck AG
2012-08-01 - 2016-05-01
Kleinkraftwerk Birseck AG
Skills
Summary
Independent Valuation of PE companies (Biotech, Medtech, Pharma, Diagnostics, High-tech). Over 1000 valuations in the US, Europe and Asia. Independent valuation expert in arbitrations, M&A, reverse mergers, financing and licensing deals. To get an impression of how we approach biotech valuations, you can download a number of papers from www.venturevaluation.com => Resource Center we wrote in Nature Biotechnology and others. We also run Biotechgate, the global Life Sciences database focused on small, upcoming companies and their licensing assets. We run the cluster and member directory database for over 40 partners around the world including AusBiotech, HKBIO, SeoulBiohub, Swiss Biotech Association, HollandBio, BioFlorida, OBN, Bio Deutschland, Maryland, California Life Science Association, and many more. This allows us to manage our unique Global Biotechnology and Life Sciences Database Biotechgate with over 55'000 company profiles, 20'000 licensing opportunities, 10'000 financing rounds, 80'000 products and 250'000 mangers of these companies. www.biotechgate.com. Specialties: Finance, valuation, merger and acquisition, reporting of high growth companies in the VC and private equity area.
